Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2008 2
2009 2
2011 1
2015 1
2016 3
2017 1
2018 1
2019 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
A Narrative Review of Intensive Group Tobacco Treatment: Clinical, Research, and US Policy Recommendations.
Kotsen C, Santorelli ML, Bloom EL, Goldstein AO, Ripley-Moffitt C, Steinberg MB, Burke MV, Foulds J. Kotsen C, et al. Among authors: burke mv. Nicotine Tob Res. 2019 Nov 19;21(12):1580-1589. doi: 10.1093/ntr/nty162. Nicotine Tob Res. 2019. PMID: 30124924 Review.
RESULTS: The review included data from 11 observational studies. In all cases, group treatment(s) had higher 4-week CO-validated quit rates (range: 35.5%-67.3%) than individual treatment(s) (range: 18.6%-53.3%). ...Group tobacco treatment is now one of the ma …
RESULTS: The review included data from 11 observational studies. In all cases, group treatment(s) had higher 4-week CO-validated quit …
Treatment of tobacco dependence.
Burke MV, Ebbert JO, Hays JT. Burke MV, et al. Mayo Clin Proc. 2008 Apr;83(4):479-83; quiz 483-4. doi: 10.4065/83.4.479. Mayo Clin Proc. 2008. PMID: 18380994 Review.
A systematic process to identify all smokers is crucial. Because tobacco dependence is characterized by relapses and remissions, clinicians should be ready to engage smokers and reengage relapsed smokers with options for new medication strategies and additional counseling …
A systematic process to identify all smokers is crucial. Because tobacco dependence is characterized by relapses and remissions, clin …
Design and Pilot Implementation of an Electronic Health Record-Based System to Automatically Refer Cancer Patients to Tobacco Use Treatment.
Jose T, Ohde JW, Hays JT, Burke MV, Warner DO. Jose T, et al. Among authors: burke mv. Int J Environ Res Public Health. 2020 Jun 6;17(11):4054. doi: 10.3390/ijerph17114054. Int J Environ Res Public Health. 2020. PMID: 32517176 Free PMC article.
Continued tobacco use after cancer diagnosis is detrimental to treatment and survivorship. The current reach of evidence-based tobacco treatments in cancer patients is low. As a part of the National Cancer Institute Cancer Center Cessation Initiative, the Mayo Clini …
Continued tobacco use after cancer diagnosis is detrimental to treatment and survivorship. The current reach of evidence-based tob
Pharmacotherapy and smoking cessation at a tobacco dependence clinic.
Steinberg MB, Foulds J, Richardson DL, Burke MV, Shah P. Steinberg MB, et al. Among authors: burke mv. Prev Med. 2006 Feb;42(2):114-9. doi: 10.1016/j.ypmed.2005.11.013. Epub 2005 Dec 20. Prev Med. 2006. PMID: 16375954
BACKGROUND: Tobacco dependence medications are effective, and combinations may offer advantages. ...METHODS: 790 smokers treated at the Tobacco Dependence Clinic in New Jersey from 2001-2003 and contacted 4 weeks after quit-date were studied. ...
BACKGROUND: Tobacco dependence medications are effective, and combinations may offer advantages. ...METHODS: 790 smokers treated at t …
An Argument for Change in Tobacco Treatment Options Guided by the ASAM Criteria for Patient Placement.
Williams JM, Steinberg ML, Kenefake AN, Burke MV. Williams JM, et al. Among authors: burke mv. J Addict Med. 2016 Sep-Oct;10(5):291-9. doi: 10.1097/ADM.0000000000000239. J Addict Med. 2016. PMID: 27466070 Free PMC article. Review.
Tobacco use is a major threat to public health in the United States, and the number one cause of preventable death. ...The ASAM Patient Placement Criteria are regularly used to determine the appropriate level of care for all substance use disorders except tobacco. T
Tobacco use is a major threat to public health in the United States, and the number one cause of preventable death. ...The ASAM Patie
Residential treatment compared with outpatient treatment for tobacco use and dependence.
Hays JT, Croghan IT, Schroeder DR, Burke MV, Ebbert JO, McFadden DD, Hurt RD. Hays JT, et al. Among authors: burke mv. Mayo Clin Proc. 2011 Mar;86(3):203-9. doi: 10.4065/mcp.2010.0703. Epub 2011 Feb 9. Mayo Clin Proc. 2011. PMID: 21307389 Free PMC article.
OBJECTIVE: To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice. PATIENTS AND METHODS: We analyzed data from 2 cohorts of cigarette smokers who received either comprehensive outpatient or intensive 8-day re …
OBJECTIVE: To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice. P …
Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence.
Burke MV, Hays JT, Ebbert JO. Burke MV, et al. Patient Prefer Adherence. 2016 Apr 1;10:435-41. doi: 10.2147/PPA.S83469. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27099479 Free PMC article. Review.
Treating tobacco dependence is the most effective way to reduce tobacco-related death and disability. Counseling and pharmacotherapy have been shown to increase tobacco abstinence rates among smokers. Varenicline is the most effective monotherapy treatment fo …
Treating tobacco dependence is the most effective way to reduce tobacco-related death and disability. Counseling and pharmacot …
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.
Ebbert JO, Wyatt KD, Zirakzadeh A, Burke MV, Hays J. Ebbert JO, et al. Among authors: burke mv. Int J Chron Obstruct Pulmon Dis. 2009;4:421-30. doi: 10.2147/copd.s6300. Epub 2009 Nov 29. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 20037681 Free PMC article. Review.
Cigarette smokers with COPD and other co-morbid conditions such as cardiovascular disease and psychiatric illnesses should receive comprehensive tobacco treatment interventions incorporating efficacious pharmacotherapies. ...
Cigarette smokers with COPD and other co-morbid conditions such as cardiovascular disease and psychiatric illnesses should receive comprehen …
Billing Practices Among US Tobacco Use Treatment Providers.
Bloom EL, Burke MV, Kotsen C, Goldstein AO, Ripley-Moffitt C, Steinberg MB, Dailey M, Hunt LE, Bars MP. Bloom EL, et al. Among authors: burke mv. J Addict Med. 2018 Sep/Oct;12(5):381-386. doi: 10.1097/ADM.0000000000000423. J Addict Med. 2018. PMID: 30044243
OBJECTIVES: The US Affordable Care Act (ACA) now requires almost all health insurance plans to cover tobacco use treatment (TUT), but TUT remains underutilized. METHODS: We conducted an anonymous online survey of US TUT providers in 2016 regarding their billing practices. …
OBJECTIVES: The US Affordable Care Act (ACA) now requires almost all health insurance plans to cover tobacco use treatment (TUT), but …
Registered nurse initiation of a tobacco intervention protocol: leading quality care.
Zarling KK, Burke MV, Gaines KA, Gauvin TR. Zarling KK, et al. Among authors: burke mv. J Cardiovasc Nurs. 2008 Sep-Oct;23(5):443-8. doi: 10.1097/01.JCN.0000317451.64778.e9. J Cardiovasc Nurs. 2008. PMID: 18728517
Hospitalization provides a unique teachable moment to treat tobacco dependence. Nurses can be effective in talking with patients about tobacco use. ...The nurse is then prompted to (1) provide information about tobacco dependence and treatment, (2) ask if the …
Hospitalization provides a unique teachable moment to treat tobacco dependence. Nurses can be effective in talking with patients abou …
16 results